Adventitial expression of recombinant eNOS gene restores NO production in arteries without endothelium.

The current study was designed to determine the effect of recombinant endothelial nitric oxide synthase (eNOS) gene expression on endothelium-dependent relaxations to bradykinin in isolated canine basilar, coronary, or femoral arteries. Arterial rings were exposed ex vivo (30 minutes at 37 degrees C) to an adenoviral vector encoding either the eNOS gene (AdCMVeNOS) or the beta-galactosidase reporter gene (AdCMVbeta-Gal). Twenty-four hours after transduction, transgene expression was evident mainly in the adventitia. Expression of recombinant proteins was much higher in basilar arteries than in coronary or femoral arteries. Rings of control, AdCMVbeta-Gal, and AdCMVeNOS arteries with and without endothelium were suspended for isometric tension recording. Levels of cGMP were measured by radioimmunoassay. In AdCMVeNOS basilar arteries with endothelium, relaxations to low concentrations of bradykinin (3 x 10(-11) to 10(-9) mol/L) were significantly augmented. In contrast, in coronary and femoral arteries with endothelium, AdCMVeNOS transduction did not affect relaxations to bradykinin. Removal of the endothelium abolished bradykinin-induced relaxations in control and AdCMVbeta-Gal basilar arteries. However, in basilar arteries transduced with AdCMVeNOS even when the endothelium was removed, stimulation with bradykinin (3 x 10(-11) to 10(-9) mol/L) caused relaxations as well as increases in cGMP production. The relaxations to bradykinin were completely blocked by an NOS inhibitor, NG-nitro-L-arginine methyl ester. Electron microscopic analysis revealed that recombinant eNOS protein was expressed in fibroblasts of the basilar artery adventitia. These results suggest that genetically modified adventitial fibroblasts may restore production of NO in cerebral arteries without endothelium. Our findings support a novel concept in vascular biology that fibroblasts in the adventitia may play a role in the regulation of vascular tone after successful transfer and expression of recombinant eNOS gene.

[1]  Z. Katušić,et al.  Expression and function of recombinant endothelial nitric oxide synthase gene in canine basilar artery. , 1997, Circulation research.

[2]  M. Laakso,et al.  Local adventitial VEGF gene transfer reduces neointima formation in rabbit carotid arteries , 1996 .

[3]  S. Milstien,et al.  Effect of tetrahydrobiopterin on endothelial function in canine middle cerebral arteries. , 1996, Circulation research.

[4]  G. Burnstock,et al.  Depression of endothelial nitric oxide synthase but increased expression of endothelin-1 immunoreactivity in rat thoracic aortic endothelium associated with long-term, but not short-term, sympathectomy. , 1996, Circulation research.

[5]  D. Collen,et al.  Adenoviral-mediated transfer of the human endothelial nitric oxide synthase gene reduces acute hypoxic pulmonary vasoconstriction in rats. , 1996, The Journal of clinical investigation.

[6]  G. Garcı́a-Cardeña,et al.  Targeting of nitric oxide synthase to endothelial cell caveolae via palmitoylation: implications for nitric oxide signaling. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[7]  A. Yao,et al.  Heterogeneity of adenovirus-mediated gene transfer in cultured thoracic aorta and renal artery of rats. , 1995, Hypertension.

[8]  B. Davidson,et al.  Adenovirus-mediated gene transfer to normal and atherosclerotic arteries. A novel approach. , 1995, Arteriosclerosis, thrombosis, and vascular biology.

[9]  C. Fielding,et al.  Plasma membrane caveolae mediate the efflux of cellular free cholesterol. , 1995, Biochemistry.

[10]  M. Moskowitz,et al.  Hypertension in mice lacking the gene for endothelial nitric oxide synthase , 1995, Nature.

[11]  R. Cohen,et al.  The role of nitric oxide and other endothelium-derived vasoactive substances in vascular disease. , 1995, Progress in cardiovascular diseases.

[12]  B. Thompson,et al.  Effect of intracarotid nitric oxide on primate cerebral vasospasm after subarachnoid hemorrhage. , 1995, Journal of neurosurgery.

[13]  B. Davidson,et al.  Adenovirus-mediated gene transfer in vivo to cerebral blood vessels and perivascular tissue. , 1995, Circulation research.

[14]  A. Dominiczak,et al.  Nitric oxide and its putative role in hypertension. , 1995, Hypertension.

[15]  Y. Kaneda,et al.  Gene therapy inhibiting neointimal vascular lesion: in vivo transfer of endothelial cell nitric oxide synthase gene. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[16]  E. Nabel,et al.  Gene therapy for cardiovascular disease. , 1995, Circulation.

[17]  Von der Leyen.  Gene therapy inhibiting neointimal vascular lesion , 1995 .

[18]  D. Spector,et al.  [3] Construction and isolation of recombinant adenoviruses with gene replacements , 1995 .

[19]  M. Villereal,et al.  Multiple intracellular Ca2+ pools exist in human foreskin fibroblast cells: the effect of BK on release and filling of the non-cytosolic Ca2+ pools. , 1995, Cell calcium.

[20]  Carl Nathan,et al.  Nitric oxide synthases: Roles, tolls, and controls , 1994, Cell.

[21]  C. Strader,et al.  Expression cloning of a human B1 bradykinin receptor. , 1994, The Journal of biological chemistry.

[22]  J Ludbrook,et al.  Repeated measurements and multiple comparisons in cardiovascular research. , 1994, Cardiovascular research.

[23]  K. Sugita,et al.  Combined effect of L-arginine and superoxide dismutase on the spastic basilar artery after subarachnoid hemorrhage in dogs. , 1994, Journal of neurosurgery.

[24]  S. Snyder,et al.  NITRIC OXIDE: A Physiologic , 1994 .

[25]  S. Snyder,et al.  Nitric oxide: a physiologic messenger molecule. , 1994, Annual review of biochemistry.

[26]  S. Moncada,et al.  The L-arginine-nitric oxide pathway. , 1993, The New England journal of medicine.

[27]  B. A. French,et al.  The Advent of Adenovirus Gene Therapy for Cardiovascular Disease , 1993, Circulation.

[28]  J. Milde,et al.  Subarachnoid Hemorrhage and Endothelial L‐Arginine Pathway in Small Brain Stem Arteries in Dogs , 1993, Stroke.

[29]  Z. Katušić,et al.  Endothelial L-arginine pathway and relaxations to vasopressin in canine basilar artery. , 1993, The American journal of physiology.

[30]  C. Strader,et al.  Cloning and pharmacological characterization of a human bradykinin (BK-2) receptor. , 1992, Biochemical and biophysical research communications.

[31]  G. Babnigg,et al.  Bradykinin-induced Ca2+ entry, release, and refilling of intracellular Ca2+ stores. Relationships revealed by image analysis of individual human fibroblasts. , 1992, The Journal of biological chemistry.

[32]  P. Vanhoutte,et al.  Vascular actions of TA 3090, a novel analog of diltiazem: interaction with endothelium-dependent relaxation in canine femoral and coronary arteries. , 1991, The Journal of pharmacology and experimental therapeutics.

[33]  S. Snyder,et al.  Nitric oxide synthase and neuronal NADPH diaphorase are identical in brain and peripheral tissues. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[34]  R. Macdonald,et al.  A review of hemoglobin and the pathogenesis of cerebral vasospasm. , 1991, Stroke.

[35]  S. Moncada,et al.  Nitric oxide: physiology, pathophysiology, and pharmacology. , 1991, Pharmacological reviews.

[36]  P. Kubes,et al.  Nitric oxide: an endogenous modulator of leukocyte adhesion. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[37]  S. Vincent,et al.  Neuronal NADPH diaphorase is a nitric oxide synthase. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[38]  S. Moncada,et al.  An L-arginine/nitric oxide pathway present in human platelets regulates aggregation. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[39]  L. Ignarro.  Biosynthesis and metabolism of endothelium-derived nitric oxide. , 1990, Annual review of pharmacology and toxicology.

[40]  A. Hassid,et al.  Nitric oxide-generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells. , 1989, The Journal of clinical investigation.

[41]  J. Sanes,et al.  Use of a recombinant retrovirus to study post‐implantation cell lineage in mouse embryos. , 1986, The EMBO journal.

[42]  G. Allen.  Cerebral arterial spasm. , 1974, Clinical neurosurgery.

[43]  J. T. Shepherd,et al.  Vasopressin Causes Endothelium‐Dependent Relaxations of the Canine Basilar Artery , 1984, Circulation research.

[44]  F. Volkert,et al.  The genetic analysis of recombination using adenovirus overlapping terminal DNA fragments. , 1983, Virology.

[45]  P. Black,et al.  Cerebrospinal fluid may nourish cerebral vessels through pathways in the adventitia that may be analogous to systemic vasa vasorum. , 1982, Journal of neurosurgery.

[46]  B. J. Alpers.  Cerebrovascular Disorders , 1981, Brain and Development.

[47]  W. E. Stern,et al.  Intravenous nitroglycerin for the treatment of chronic cerebral vasoconstriction in the primate. , 1981, Journal of neurosurgery.

[48]  R. Furchgott,et al.  The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine , 1980, Nature.

[49]  N. Jones,et al.  Isolation of adenovirus type 5 host range deletion mutants defective for transformation of rat embryo cells , 1979, Cell.

[50]  F. Graham,et al.  Characteristics of a human cell line transformed by DNA from human adenovirus type 5. , 1977, The Journal of general virology.

[51]  W. A. Newman Dorland,et al.  Dorland's Illustrated Medical Dictionary , 1974 .

[52]  G. Allen,et al.  Cerebral arterial spasm. 1. In vitro contractile activity of vasoactive agents on canine basilar and middle cerebral arteries. , 1974, Journal of neurosurgery.

[53]  O. H. Lowry,et al.  Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.